Preserving Patient Access to Home Infusion Act

House Bill 6218 - Preserving Patient Access to Home Infusion Act: Overview, Status, and Impact

Hozzl · 2022-02-09T03:11:38Z

Explore the details of House Bill 6218 Preserving Patient Access to Home Infusion Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/9/2022, 3:11 AM

Congressional Summary of HR 6218

Preserving Patient Access to Home Infusion Act

This bill specifically includes pharmacy services and certain self-administered drugs as part of covered home infusion therapy under Medicare, and specifies that certain payment components still apply regardless of whether or not a qualified supplier is physically present in the beneficiary's home.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 6218

Bill HR 6218 is currently in the status of Bill Introduced since March 12, 2020. Bill HR 6218 was introduced during Congress 116 and was introduced to the House on March 12, 2020. Bill HR 6218's most recent activity was Referred to the Subcommittee on Health. as of March 12, 2020

Bipartisan Support of Bill HR 6218

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 6218

Primary Policy Focus

Health

Potential Impact Areas

- Drug therapy

- Health care coverage and access

- Home and outpatient care

- Medicare

Alternate Title(s) of Bill HR 6218

Preserving Patient Access to Home Infusion Act

To amend title XVIII of the Social Security Act to clarify congressional intent and preserve patient access to home infusion therapy under the Medicare program, and for other purposes.

Preserving Patient Access to Home Infusion Act